146 related articles for article (PubMed ID: 38570343)
1. Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric study.
Shehaj I; Krajnak S; Rad MT; Gasimli B; Hasenburg A; Karn T; Schmidt M; Müller V; Becker S; Gasimli K
J Cancer Res Clin Oncol; 2024 Apr; 150(4):174. PubMed ID: 38570343
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.
Kriegmair MC; Mandel P; Porubsky S; Dürr J; Huck N; Nuhn P; Pfalzgraf D; Michel MS; Wagener N
Horm Cancer; 2017 Apr; 8(2):127-134. PubMed ID: 28247362
[TBL] [Abstract][Full Text] [Related]
3. Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer.
Yang X; Li X; Dong Y; Fan Y; Cheng Y; Zhai L; Zhang S; Zhou J; Wang J
Front Endocrinol (Lausanne); 2021; 12():780769. PubMed ID: 34975754
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between metabolic syndrome and prognosis of patients with clear cell renal cell carcinoma].
Zuo MN; DU YQ; Yu LP; Dai X; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):636-643. PubMed ID: 35950385
[TBL] [Abstract][Full Text] [Related]
5. Influence of metabolic syndrome on survival of patients with localized renal clear cell carcinoma: A retrospective cohort study in China.
Liang Y; Zhang C; Luo J; He Y; Zhang Y; Quan Z; Yang L
Urol Oncol; 2023 May; 41(5):257.e19-257.e26. PubMed ID: 36967252
[TBL] [Abstract][Full Text] [Related]
6. Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women.
Park B
J Gynecol Oncol; 2022 Jul; 33(4):e35. PubMed ID: 35320886
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome and its components as prognostic factors in metastatic colorectal cancer.
Reed M; Patrick C; Croft B; Walde N; Voutsadakis IA
Indian J Gastroenterol; 2019 Feb; 38(1):15-22. PubMed ID: 30701442
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Syndrome in Endometrial Cancer Patients: Systematic Review.
Adambekov S; Yi Y; Fabio A; Miljkovic I; Edwards RP; Lopa S; Linkov F
Metab Syndr Relat Disord; 2019 Jun; 17(5):241-249. PubMed ID: 30932741
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study.
Arthur RS; Kabat GC; Kim MY; Wild RA; Shadyab AH; Wactawski-Wende J; Ho GYF; Reeves KW; Kuller LH; Luo J; Beebe-Dimmer J; Simon MS; Strickler H; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2019 Apr; 30(4):355-363. PubMed ID: 30788634
[TBL] [Abstract][Full Text] [Related]
10. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and endometrial cancer risk.
Rosato V; Zucchetto A; Bosetti C; Dal Maso L; Montella M; Pelucchi C; Negri E; Franceschi S; La Vecchia C
Ann Oncol; 2011 Apr; 22(4):884-889. PubMed ID: 20937645
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.
Billingsley CC; Cansino C; O'Malley DM; Cohn DE; Fowler JM; Copeland LJ; Backes FJ; Salani R
Gynecol Oncol; 2016 Mar; 140(3):405-8. PubMed ID: 26801939
[TBL] [Abstract][Full Text] [Related]
14. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors.
Awwad F; Ozga AK; Amin T; Schlueter C; Kailani S; Perez D; Wolter S; Sauter G; Izbicki J; Lohse AW; Schrader J
Neuroendocrinology; 2022; 112(12):1225-1236. PubMed ID: 35354139
[TBL] [Abstract][Full Text] [Related]
16. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.
Ko EM; Walter P; Clark L; Jackson A; Franasiak J; Bolac C; Havrilesky L; Secord AA; Moore DT; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2014 Apr; 133(1):28-32. PubMed ID: 24680588
[TBL] [Abstract][Full Text] [Related]
17. Prolonged progression-free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer.
Wang NF; Tang HM; Liu FL; Hong QY
Chin Med J (Engl); 2020 Apr; 133(7):786-791. PubMed ID: 32195672
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes.
Insin P; Prueksaritanond N
Asian Pac J Cancer Prev; 2018 May; 19(5):1295-1302. PubMed ID: 29802690
[TBL] [Abstract][Full Text] [Related]
19. Changes in metabolic syndrome and the risk of breast and endometrial cancer according to menopause in Korean women.
Tran TXM; Kim S; Park B
Epidemiol Health; 2023; 45():e2023049. PubMed ID: 37139668
[TBL] [Abstract][Full Text] [Related]
20. Number of Metabolic Syndrome Components Is the Central Predictor of the Impact of Metabolic Syndrome on Outcome of Percutaneous Nephrolithotomy in Staghorn Nephrolithiasis.
Xu P; Wang J
J Endourol; 2019 Nov; 33(11):946-953. PubMed ID: 31333070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
